City
Epaper

Production of Sputnik COVID-19 vaccine in India expected to start in August, says Indian envoy to Russia

By ANI | Updated: May 22, 2021 13:10 IST

The production of the Sputnik COVID-19 vaccine in India is expected to start in August, said Indian envoy to Russia, Bala Venkatesh Varma, adding that Russia has supplied over 2 lakh doses of the vaccine to India.

Open in App

The production of the Sputnik COVID-19 vaccine in India is expected to start in August, said Indian envoy to Russia, Bala Venkatesh Varma, adding that Russia has supplied over 2 lakh doses of the vaccine to India.

"For Sputnik, 150,000 doses plus 60,000 doses supplied to India. By May-end about 3 million doses will be supplied in bulk. Those will be filled in India. In June, it is expected to increase to 5 million and production in India expected to start in August," Varma said.

The Indian Envoy also informed that Sputnik will be produced in India in three phases.

"It will be produced in India in three phases. First, supply from Russia - fully made - which has already started. Second, RDIF will send to India in bulk. It will be ready for use but it will have to be filled in various bottles in India," Varma said.

"And in the third phase, the Russian side will transfer the technology to an Indian company and the Indian company will produce it fully. All these three put together will be about 850 million doses," he added.

Taking about the Sputnik Light vaccine, the Ambassador also said that New Delhi hopes that the Russian Sputnik Light vaccine will be approved for use in India.

"Russian side has also proposed Sputnik Light. The regulatory approvals for that in India are still not completed. But once those regulatory approvals are given, then Sputnik Light will be one more area of cooperation between India and Russia," he said.

Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of the Sputnik V coronavirus vaccine, according to the Russian Direct Investment Fund (RDIF), the sovereign wealth fund marketing the vaccine abroad.

"The single-dose Sputnik Light vaccine demonstrated 79.4 percent efficacy according to analyzed data taken from 28 days after the injection was administered. An efficacy level of near 80 percent is higher than that of many two-dose vaccines," the RDIF said in a statement.

The Sputnik V vaccine was registered in India in April.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Russian Direct Investment FundBala venkatesh varmaindiaNew DelhiThe new delhi municipal councilDelhi south-westIndiUk-indiaRepublic of indiaIndia india
Open in App

Related Stories

EntertainmentAjith Kumar Injured in Fan Frenzy After Padma Bhushan Award Ceremony, Actor Hospitalized In Chennai

MumbaiMumbai: Gold Sales Cross ₹12,000 Crores Nationwide on Akshaya Tritiya; Mumbai MMR Sees ₹800 Crores Trade

NationalAkshaya Tritiya 2025: Gold Market Sees Huge Footfall Despite Price Hike (Watch Video)

MaharashtraOver 10,000 Pakistani Nationals Traced in Maharashtra and Delhi Post-Palgham Terror Attack

MumbaiViral Sighting of Tesla Cybertruck Near Mumbai Stirs EV Enthusiasm (Photos)

International Realted Stories

International45-member Japanese delegation arrives in Guwahati on 3-day Assam visit

InternationalEAM Jaishankar discusses Pahalgam terror attack with Russian FM Lavrov

InternationalPresident Murmu recieves Angola's President for banquet in Rashtrapati Bhavan

InternationalRussia calls for settlements of disagreement between India, Pak after Pahalgam terror attack

InternationalIndia bans Pakistani ships from ports to 'ensure safety of assets' in aftermath of Pahalgam attack